Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06147999 · ClinicalTrials.gov registry record · NA
Impact of a Biophoton Therapy on Patients With Brain Disorders
A NA study of Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury, sponsored by First Institute of All Medicines.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06147999 is a NA study of Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury that is actively recruiting participants, run by First Institute of All Medicines. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06147999, a NA study of Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury, is actively recruiting participants, sponsored by First Institute of All Medicines.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. About 80 patients with brain disorder (Alzheimer's disease, dementia, stroke, traumatic brain injury, Parkinson's disease) will participate in the intervention clinical study at the Tesla MedBed Center located in Butler, PA.
Conditions Studied
Interventions
- DEVICE Biophotonizer - a Biophoton Generator
Study Locations (1)
Pennsylvania
- Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001 - Butler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-11-08 |
| Est. Completion | 2026-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06147999
The ClinicalTrials.gov registry entry for NCT06147999 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is First Institute of All Medicines, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Biophotonizer - a Biophoton Generator is the first listed.
NCT06147999 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06147999 about?
NCT06147999 is a clinical study titled "Impact of a Biophoton Therapy on Patients With Brain Disorders". Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting a...
What is the current status of trial NCT06147999?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-11-08. Estimated completion is 2026-11-08.
What conditions does trial NCT06147999 study?
This clinical trial studies the following conditions: Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury.
What interventions are being tested in trial NCT06147999?
The interventions under investigation include: Biophotonizer - a Biophoton Generator (DEVICE).
Who is sponsoring clinical trial NCT06147999?
This trial is sponsored by First Institute of All Medicines, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06147999 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.